Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check5 days agoChange DetectedA new revision label v3.5.4 was added to the history and the previous v3.5.3 was removed. This indicates an update to the page's revision metadata.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry, v3.5.3, was added to the record history, replacing the previous v3.5.2. This indicates an updated build/version of the page in the history.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.4.3 has been added, replacing v3.4.2 in the record history.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was added and notices including 'Notice Because of a lapse in government funding...' and 'Revision: v3.4.1' were removed from the history; the rest of the study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.